CP-316311

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCP-316311
Drug Alias NameCorticotropin releasing factor antagonist - PfizerCorticotropin releasing hormone antagonist - PfizerCP-316311
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFormer Serbia and MontenegroUnited StatesRussian Federation
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A